$ARWR
Arrowhead Research Corporation
XNAS•Health Care•Pharmaceutical Preparations
$62.35
▼-2.87%-$1.84
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateArrowhead Research Corporation
XNAS•Health Care•Pharmaceutical Preparations
Why is ARWR down today? It is at $62.35 (-2.87%), and our scanner flagged it 143 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARWR spikes, and full due diligence on ARWR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARWR 143 times in the last 30 days. Create a free account to track $ARWR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ARWR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on ARWR today, peaking at 37.6x its normal volume.
Likely catalystArrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results, from an SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
3,100,776 new shares · About $188.3M in size · Priced at $64.5/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Perry Michael S Director | Sold (automatic/other) | -12K | sold 9.4% | 111K | $1.0M at $87.30 | Aug 18, 26 |
Olukotun Adeoye Y Director | Sold (automatic/other) | -2K | sold 6.0% | 32K | $174K at $86.96 | Aug 18, 26 |
Cohen Matthew Gregory Director | Acquired (grant/award) | +12K | n/a | 12K | n/a | Jun 15, 26 |
Lu Hongbo Director | Sold (automatic/other) | -3K | sold 5.4% | 52K | $228K at $76.88 | May 12, 26 |
Hamilton James C Officer | Sold (automatic/other) | -10K | sold 4.2% | 227K | $750K at $75.00 | Apr 23, 26 |
Apel Daniel Joseph Officer | Sold (automatic/other) | -13K | sold 7.4% | 163K | $918K at $70.11 | Apr 22, 26 |
Hamilton James C Officer | Sold (automatic/other) | -10K | sold 4.0% | 237K | $642K at $64.19 | Mar 5, 26 |
Apel Daniel Joseph Officer | Acquired (grant/award) | +75K 0.05% of company | added 74% | 176K | n/a | Jan 6, 26 |
O'Brien Patrick Officer | Sold (automatic/other) | -3K | sold 0.5% | 472K | n/a | Jan 6, 26 |
O'Brien Patrick Officer | Acquired (grant/award) | +75K 0.05% of company | added 16% | 547K | n/a | Jan 6, 26 |
Hamilton James C Officer | Acquired (grant/award) | +75K 0.05% of company | added 44% | 247K | n/a | Jan 6, 26 |
Hamilton James C Officer | Sold (automatic/other) | -40K 0.03% of company | sold 19% | 172K | $2.5M at $61.24 | Jan 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
ARWR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 4 unusual-volume and momentum alerts on ARWR today, peaking at 37.6x its normal volume.
ARWR last traded at $62.35, down 2.87% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Arrowhead Research Corporation (ARWR) is next expected to report earnings on Tuesday, November 24, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ARWR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARWR 143 times in the last 30 days.
ARWR (Arrowhead Research Corporation) trades on XNAS, with a market cap of about $9.07B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARWR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARWR discussion
Sign in to ask a question or join the discussion.